PCI Synthesis, Inc., a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, has strengthened ties with the Greater Boston life sciences community with the signing of a dozen local biotech and medtech customers. “This year has been one of tremendous growth for PCI,” said Ed Price, president, PCI Synthesis. “We’ve reached major milestones with customers, products, staff and awards, testament to the ...